IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Ticker index
GH
Ticker

GH

Congressional Trades
2
by 1 members
Ticker disclosure brief

Congressional disclosure records for GH

A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.

Latest receipt
Sheldon Whitehouse
BUY · 2025-11-21
Largest range
$1K – $15K
Sheldon Whitehouse
Longest observed gap
10d
Sheldon Whitehouse
Highest 30d vs SPY
39.5%
Sheldon Whitehouse
Purchase rows
2
100%
Sale rows
0
0%
Disclosed midpoint
$16K
range estimate
Unique Traders
1
members
Disclosure timing method

Observed filing gaps are not notice-date findings

The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.

Party Breakdown

Democrats2 · 100%
Republicans0 · 0%

Lobbying filings

all →
  • 2026-04-20$241K
    GUARDANT HEALTH
    precision diagnostics and preventive screening innovation precision diagnostics, cancer care, and preventive screening innovation
  • 2026-04-20$80K
    GUARDANT HEALTH INC.
    Cancer screening access. Precision diagnostics, cancer care and preventive screening innovation.
  • 2026-04-13$16K
    GUARDANT HEALTH INC.
    CRUSH RFI CMS-9883-P: Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) FDA-2025-N-4622 Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use with a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order
  • 2026-03-19$0
    GUARDANT HEALTH
  • 2026-01-20$741K
    GUARDANT HEALTH
    precision diagnostics and preventive screening innovation precision diagnostics, cancer care, and preventive screening innovation
  • 2026-01-20$80K
    GUARDANT HEALTH INC.
    Cancer screening access. Precision diagnostics, cancer care and preventive screening innovation.
  • 2026-01-19$30K
    GUARDANT HEALTH
    Matters related to health screening.
  • 2026-01-16$16K
    GUARDANT HEALTH INC.
    Quality measures in Medicare and colorectal cancer screening Utilization management in Medicare Advantage
  • 2025-12-23$0
    GUARDANT HEALTH INC.
  • 2025-10-20$80K
    GUARDANT HEALTH INC.
    Cancer screening access. Precision diagnostics, cancer care and preventive screening innovation.
Loading trade analytics…

All Disclosed Trades

Page 1 · 2 of 2 shown
DateMemberActionAmountObserved GapReceipt
2025-11-21DSheldon WhitehouseBUY$1K – $15K10dreceipt →
2025-11-21DSheldon WhitehouseBUY$1K – $15K10dreceipt →

“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.